Form 4 Filing for CAPRICOR THERAPEUTICS, INC. (CAPR)

This filing details transactions made by Karen Krasney, EVP, GENERAL COUNSEL of CAPRICOR THERAPEUTICS, INC. On June 22, 2026, Krasney acquired 500 shares of Common Stock at $3.18 per share and sold 500 shares at $30.00 per share, pursuant to a 10b5-1 trading plan. Additionally, stock options (right to buy) for 500 shares were exercised. On June 24, 2026, Krasney acquired 400 shares of Common Stock at $3.18 per share and sold 400 shares at $30.00 per share, also under the 10b5-1 plan. Stock options for 400 shares were exercised. The transactions indicate a net change in direct ownership of common stock and exercise of stock options.